Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13968072 | 0.93 | TLR7 (0.86) | TLR7TLR8 | |
| SCHEMBL13976710 | 0.89 | TLR7 (0.80) | TLR7TLR8 | |
| SCHEMBL30577190 | 0.87 | TLR7 (1.00) | TLR7TLR8 | |
| SCHEMBL13837354 | 0.87 | TLR7 (1.00) | TLR7TLR8 | |
| SCHEMBL13976720 | 0.87 | TLR7 (0.77) | TLR7TLR8 | |
| Hydrochloric Acid SCHEMBL15881955 | 0.86 | TLR7 (0.98) | TLR7TLR8 | |
| SCHEMBL13837318 | 0.86 | TLR7 (1.00) | TLR7TLR8 | |
| SCHEMBL15703349 | 0.84 | TLR7 (1.00) | TLR7TLR8 | |
| SCHEMBL13968061 | 0.83 | TLR7 (0.97) | TLR7TLR8 | |
| SCHEMBL13968074 | 0.83 | TLR7 (1.00) | TLR7TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10208037-B2 | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds | THE UNIVERSITY OF KANSAS (US) | 2019-02-19 | — | — | US | disclosed |
| US-10208037-B2 | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds | THE UNIVERSITY OF KANSAS (US) | 2019-02-19 | — | — | US | disclosed |
| US-20180134701-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | THE UNIVERSITY OF KANSAS | 2018-05-17 | — | — | US | disclosed |
| US-20180134701-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | THE UNIVERSITY OF KANSAS | 2018-05-17 | — | — | US | disclosed |
| US-20180134701-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | THE UNIVERSITY OF KANSAS | 2018-05-17 | — | — | US | disclosed |
| US-20170260184-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | UNIV KANSAS (US) | 2017-09-14 | — | — | US | disclosed |
| US-20170260184-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | UNIV KANSAS (US) | 2017-09-14 | — | — | US | disclosed |
| US-20170260184-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | UNIV KANSAS (US) | 2017-09-14 | — | — | US | disclosed |
| US-20170029421-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | UNIV KANSAS (US) | 2017-02-02 | — | — | US | disclosed |
| US-20170029421-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | UNIV KANSAS (US) | 2017-02-02 | — | — | US | disclosed |
| US-9441005-B2 | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds | UNIVERSITY OF KANSAS (US) | 2016-09-13 | — | — | US | disclosed |
| US-20140256922-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-09-11 | — | — | US | disclosed |
| US-20140256922-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-09-11 | — | — | US | disclosed |
| US-20140256922-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-09-11 | — | — | US | disclosed |
| US-8728486-B2 | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds | UNIVERSITY OF KANSAS (US) | 2014-05-20 | — | — | US | disclosed |
| US-8728486-B2 | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds | UNIVERSITY OF KANSAS (US) | 2014-05-20 | — | — | US | disclosed |
| US-8728486-B2 | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds | UNIVERSITY OF KANSAS (US) | 2014-05-20 | — | — | US | disclosed |
| US-20120294885-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | THE UNIVERSITY OF KANSAS (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120294885-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | THE UNIVERSITY OF KANSAS (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120294885-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | THE UNIVERSITY OF KANSAS (US) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134701-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | TLR7, TLR8, TLR3 | TLR7 1/4885TLR8 2/4885 |
| US-20170029421-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | TLR7, TLR8, TLR3 | TLR7 1/4885TLR8 2/4885 |
| US-20120294885-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | TLR7, TLR8, TLR3 | TLR7 1/4885TLR8 2/4885 |
| US-10208037-B2 | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds | TLR7, TLR8, TLR3 | TLR7 1/4885TLR8 2/4885 |
| US-20140256922-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | TLR7, TLR8, TLR3 | TLR7 1/4885TLR8 2/4885 |
| US-20170260184-A1 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | TLR7, TLR8, TLR3 | TLR7 1/4885TLR8 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.